| AMP | No. of amino acids | Susceptible cancer cells | References |
| Pardaxin | 33 | Murine fibrosarcoma | [91] | Dermaseptin B2 | 33 | Prostate adenocarcinoma cell line PC3 | [92] | Magainins | 21 to 27 | HL-60 human promyelocytic leukemia cells, human lung carcinoma cells | [93] | Gaegurins | 24 | HCT116 colon and MCF-7 breast carcinoma cells | [86] | Melittin | 26 | U937 human monocytic leukemia cells, Du145 prostate carcinoma cells, SKOV3 ovarian carcinoma cells, B16 murine melanoma cells, BEL-7402 human hepatocellular carcinoma cells | [94, 95] | LL-37 | | Human oral squamous carcinoma cells, KB human squamous cancer cell lines | [96] | Cecropins | 24–39 | HL-60 human promyelocytic leukemia cells, CCRF-SB human lymphoblastic leukemia cells, EJ human bladder carcinoma cells, ascitic colon adenocarcinoma cells, bladder tumour cells lines, RT4, 647V, J82, 486P and benign fibroblast cell line, 3T6 | [97–101] | BMAP-27, BMAP-28 | 27, 28 | Human leukemia cells, CEM-CCRF human T leukemia cells, U937 and K562 human leukemia cell lines | [102] | Defensins | 29 to 45 | Raji human B-lymphoma cells, human oral squamous carcinoma cells, MOT mouse teratocarcinoma cells, fibroblast and epithelial cells | [103, 104] | Lactoferricin (Lfcin B) | 25 | Human leukemia and breast carcinoma cells, human endothelial cells | [105, 106] | Tachyplesin I | 17 | Human TSU prostate carcinoma cells, endothelial cells, B16 melanoma cells, SMMC-7721 human hepatoma cells, BGC-83 human gastric adenocarcinoma cells. | [107] | PR-39 | 39 | Human hepatocellular carcinoma cell lines | [108] | Cecropin-Melittin (CA-ME) | 20 | Human small cell lung cancer cell line | [109] | Cecropin-Magainin (CA-MA) | 20 | Jurkat T leukemia cells, K562 chronic myeloid leukemia cells | [55] |
|
|